Switch theme
Sign up to access all valuation multiples
Amplitude Surgical is engaged in developing and marketing products for orthopedic surgery. It offers a range of orthopedic products for primary and revision surgery aimed at treating pathologies of the hip, knee, and lower extremities for foot and ankle surgery. The company also provides AMPLIVISION, a computer-assisted surgical system; the i.M.A.G.E., a single-use made-to-measure instrument system; and the E.T.O.I.L.E, a technology platform for anterior approaches resulting in less-invasive surgery.
2011
460
LTM Revenue n/a
LTM EBITDA n/a
$416M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Amplitude Surgical has a last 12-month revenue of n/a and a last 12-month EBITDA of n/a.
In the most recent fiscal year, Amplitude Surgical achieved revenue of $114M and an EBITDA of $25.3M.
Amplitude Surgical expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Amplitude Surgical valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $108M | $114M | XXX | XXX | XXX |
| Gross Profit | $72.2M | $84.9M | XXX | XXX | XXX |
| Gross Margin | 67% | 75% | XXX | XXX | XXX |
| EBITDA | $19.7M | $25.3M | XXX | XXX | XXX |
| EBITDA Margin | 18% | 22% | XXX | XXX | XXX |
| Net Profit | -$4.7M | $42.2M | XXX | XXX | XXX |
| Net Margin | -4% | 37% | XXX | XXX | XXX |
| Net Debt | $116M | $64.6M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, Amplitude Surgical's stock price is EUR 6 (or $6).
Amplitude Surgical has current market cap of EUR 288M (or $309M), and EV of EUR 388M (or $416M).
See Amplitude Surgical trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $416M | $309M | XXX | XXX | XXX | XXX | n/a |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, Amplitude Surgical has market cap of $309M and EV of $416M.
Amplitude Surgical's trades at n/a LTM EV/Revenue multiple, and n/a LTM EBITDA.
Analysts estimate Amplitude Surgical's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Amplitude Surgical and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $416M | XXX | XXX | XXX |
| EV/Revenue | n/a | XXX | XXX | XXX |
| EV/EBITDA | n/a | XXX | XXX | XXX |
| P/E | n/a | XXX | XXX | XXX |
| P/E/Growth | n/a | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpAmplitude Surgical's NTM/LTM revenue growth is n/a
Amplitude Surgical's revenue per employee for the last fiscal year averaged $0.2M, while opex per employee averaged $0.2M for the same period.
Over next 12 months, Amplitude Surgical's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Amplitude Surgical's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Amplitude Surgical and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | 6% | XXX | XXX | XXX | XXX |
| EBITDA Margin | n/a | XXX | XXX | XXX | XXX |
| EBITDA Growth | 29% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | n/a | XXX | XXX | XXX | XXX |
| Revenue per Employee | $0.2M | XXX | XXX | XXX | XXX |
| Opex per Employee | $0.2M | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | 13% | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | 3% | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | 2% | XXX | XXX | XXX | XXX |
| Opex to Revenue | 67% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Philips | XXX | XXX | XXX | XXX | XXX | XXX |
| Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
| InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
| Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Amplitude Surgical acquired XXX companies to date.
Last acquisition by Amplitude Surgical was XXXXXXXX, XXXXX XXXXX XXXXXX . Amplitude Surgical acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was Amplitude Surgical founded? | Amplitude Surgical was founded in 2011. |
| Where is Amplitude Surgical headquartered? | Amplitude Surgical is headquartered in France. |
| How many employees does Amplitude Surgical have? | As of today, Amplitude Surgical has 460 employees. |
| Who is the CEO of Amplitude Surgical? | Amplitude Surgical's CEO is Mr. Olivier Jallabert. |
| Is Amplitude Surgical publicy listed? | Yes, Amplitude Surgical is a public company listed on PAR. |
| What is the stock symbol of Amplitude Surgical? | Amplitude Surgical trades under AMPLI ticker. |
| When did Amplitude Surgical go public? | Amplitude Surgical went public in 2015. |
| Who are competitors of Amplitude Surgical? | Similar companies to Amplitude Surgical include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
| What is the current market cap of Amplitude Surgical? | Amplitude Surgical's current market cap is $309M |
| What is the current revenue growth of Amplitude Surgical? | Amplitude Surgical revenue growth between 2023 and 2024 was 6%. |
| Is Amplitude Surgical profitable? | Yes, Amplitude Surgical is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
